Section Arrow
PRFX.NASDAQ
- PainReform Ltd
(Financial Status)
Quotes are at least 15-min delayed:2025/02/23 10:14 EST
Last
 3.16
-0.32 (-9.20%)
Day High 
3.3599 
Prev. Close
3.48 
1-M High
6.65 
Volume 
144.87K 
Bid
3.27
Ask
3.28
Day Low
3.1 
Open
3.35 
1-M Low
2.7206 
Market Cap 
3.04M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.14 
20-SMA 3.2 
50-SMA 3.43 
52-W High 61.2 
52-W Low 1.7272 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-147.36/-35.22
Enterprise Value
3.07M
Balance Sheet
Book Value Per Share
-2.33
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 10:14 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.